These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9426433

  • 1. Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies.
    Juweid M, Sharkey RM, Swayne LC, Goldenberg DM.
    Surgery; 1997 Dec; 122(6):1156-65. PubMed ID: 9426433
    [Abstract] [Full Text] [Related]

  • 2. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM, Gratz S, Markus PM, Dunn RM, Hüfner M, Schauer A, Fischer M, Munz DL, Becker H, Becker W.
    Cancer; 1997 Dec 15; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [Abstract] [Full Text] [Related]

  • 3. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
    Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Herskovic T, Hanley D, Markowitz A, Dunn R, Siegel J, Kamal T, Goldenberg DM.
    J Clin Oncol; 1996 Apr 15; 14(4):1209-17. PubMed ID: 8648376
    [Abstract] [Full Text] [Related]

  • 4. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J, Peltier P, Bardet S, Vuillez JP, Bachelot I, Denet S, Olivier P, Leccia F, Corcuff B, Huglo D, Proye C, Rouvier E, Meyer P, Chatal JF.
    J Nucl Med; 1998 Jul 15; 39(7):1172-8. PubMed ID: 9669389
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
    Kebebew E, Kikuchi S, Duh QY, Clark OH.
    Arch Surg; 2000 Aug 15; 135(8):895-901. PubMed ID: 10922248
    [Abstract] [Full Text] [Related]

  • 6. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen.
    Juweid M, Sharkey RM, Behr T, Swayne LC, Rubin AD, Hanley D, Herskovic T, Markowitz A, Siegel J, Goldenberg DM.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5946s-5951s. PubMed ID: 7493375
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies.
    Juweid M, Sharkey RM, Behr T, Swayne LC, Herskovic T, Pereira M, Rubin AD, Hanley D, Dunn R, Siegel J, Goldenberg DM.
    J Nucl Med; 1996 Jun 01; 37(6):905-11. PubMed ID: 8683309
    [Abstract] [Full Text] [Related]

  • 8. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP, Peltier P, Caravel JP, Chetanneau A, Saccavini JC, Chatal JF.
    J Clin Endocrinol Metab; 1992 Jan 01; 74(1):157-63. PubMed ID: 1727816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.
    Juweid ME, Hajjar G, Swayne LC, Sharkey RM, Suleiman S, Herskovic T, Pereira M, Rubin AD, Goldenberg DM.
    Cancer; 1999 Apr 15; 85(8):1828-42. PubMed ID: 10223579
    [Abstract] [Full Text] [Related]

  • 11. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM, Wulst E, Radetzky S, Blumenthal RD, Dunn RM, Gratz S, Rave-Fränk M, Schmidberger H, Raue F, Becker W.
    Cancer Res; 1997 Dec 01; 57(23):5309-19. PubMed ID: 9393755
    [Abstract] [Full Text] [Related]

  • 12. Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
    Magnani P, Paganelli G, Songini C, Samuel A, Sudati F, Siccardi AG, Fazio F.
    Br J Cancer; 1996 Sep 01; 74(5):825-31. PubMed ID: 8795589
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM, Sharkey RM, Juweid MI, Dunn RM, Ying Z, Zhang CH, Siegel JA, Gold DV, Goldenberg DM.
    Cancer Res; 1996 Apr 15; 56(8):1805-16. PubMed ID: 8620497
    [Abstract] [Full Text] [Related]

  • 14. Improved results of cervical reoperation for medullary thyroid carcinoma.
    Moley JF, Dilley WG, DeBenedetti MK.
    Ann Surg; 1997 Jun 15; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
    [Abstract] [Full Text] [Related]

  • 15. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
    Bodet-Milin C, Faivre-Chauvet A, Carlier T, Rauscher A, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F.
    J Nucl Med; 2016 Oct 15; 57(10):1505-1511. PubMed ID: 27230928
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
    O'Byrne KJ, O'Hare N, Sweeney E, Freyne PJ, Cullen MJ.
    Nucl Med Commun; 1996 Sep 15; 17(9):810-6. PubMed ID: 8895910
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Fiche M, Gautherot E, Barbet J, Chatal JF.
    J Nucl Med; 1998 Sep 15; 39(9):1608-13. PubMed ID: 9744353
    [Abstract] [Full Text] [Related]

  • 20. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L, Sullo P, Klain M, Lupoli G, Cascone E, Salvatore M.
    Q J Nucl Med; 1995 Dec 15; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.